Search Results - "Avril, Norbert"

Refine Results
  1. 1
  2. 2

    Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study by Antunes, Jacob, Viswanath, Satish, Rusu, Mirabela, Valls, Laia, Hoimes, Christopher, Avril, Norbert, Madabhushi, Anant

    Published in Translational oncology (01-04-2016)
    “…Abstract Studying early response to cancer treatment is significant for patient treatment stratification and follow-up. Although recent advances in positron…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer by KAYANI, Irfan, AVRIL, Norbert, LIM, Louise, DICKSON, John, ELL, Peter, REYNOLDS, Andrew, POWLES, Thomas, BOMANJI, Jamshed, CHOWDHURY, Simon, ROCKALL, Andrea, SAHDEV, Anju, NATHAN, Paul, WILSON, Peter, SHAMASH, Jonathan, SHARPE, Kevin

    Published in Clinical cancer research (15-09-2011)
    “…To test the hypothesis that sequential (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is a correlative marker in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy by Li, Yan, Awan, Musaddiq J., Chang, Tangel, Lavertu, Pierre, Zender, Chad, Rezaee, Rod, Fowler, Nicole, Wasman, Jay, Avril, Norbert E., Chen, Nianyong, Machtay, Mitchell, Yao, Min

    “…Purpose The purpose of this study was to retrospectively review the role of post-treatment (post-tx) FDG-PET/CT scans in patients receiving postoperative…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Monitoring response to treatment in patients utilizing PET by Avril, Norbert E, Weber, Wolfgang A

    Published in The Radiologic clinics of North America (01-01-2005)
    “…Establishing new surrogate end points for monitoring response to treatment is needed for current therapy modalities and for new therapeutic strategies…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring by Murray, Iain, Kalemis, Antonis, Glennon, Joe, Hasan, Syed, Quraishi, Shuaib, Beyer, Thomas, Avril, Norbert

    “…Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to…”
    Get full text
    Journal Article
  14. 14

    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer by Avril, Stefanie, Muzic, Raymond F., Plecha, Donna, Traughber, Bryan J., Vinayak, Shaveta, Avril, Norbert

    Published in The Journal of nuclear medicine (1978) (01-02-2016)
    “…Changes in tumor metabolic activity have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the neoadjuvant setting…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer by Sassen, Stefanie, MD, Schmalfeldt, Barbara, MD, Avril, Norbert, MD, Kuhn, Walther, MD, Busch, Raymonde, MSc, Höfler, Heinz, MD, Fend, Falko, MD, Nährig, Jörg, MD

    Published in Human pathology (01-06-2007)
    “…Summary To date, no histopathologic criteria have been established to describe treatment response after neoadjuvant chemotherapy in ovarian cancer. The aim of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Neoadjuvant therapy of esophageal squamous cell carcinoma : Response evaluation by positron emission tomography by BRUCHER, Bjorn L. D. M, WEBER, Wolfgang, BAUER, Markus, FINK, Ullrich, AVRIL, Norbert, STEIN, T. Hubert J, WERNER, Martin, ZIMMERMAN, Frank, SIEWERT, J. Rüdiger, SCHWAIGER, Markus

    Published in Annals of surgery (01-03-2001)
    “…To evaluate the use of positron emission tomography using [(18)F]-fluorodeoxyglucose (FDG-PET) to assess the response to neoadjuvant radiotherapy and…”
    Get full text
    Journal Article
  20. 20

    The clinical advances of fluorine-2-D-deoxyglucose - positron emission tomography/computed tomography in urological cancers by Avril, Norbert, Dambha, Fatima, Murray, Iain, Shamash, Jonathan, Powles, Tom, Sahdev, Anju

    Published in International journal of urology (01-06-2010)
    “…Fluorine‐18 labeled fluorine‐2‐D‐deoxyglucose (FDG) is the most frequently used positron emission tomography (PET) probe but it has certain limitations when…”
    Get full text
    Journal Article